FTC sues main pharmacy profit supervisors in excess of insulin charges The agency introduced action in opposition to Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list price of daily life-conserving insulin medications. Sanders quickly condemned the transfer in a press release https://arizona-hard-tea-nutritio27271.csublogs.com/37089608/5-simple-techniques-for-healthcare-news